TNFSF10 and non-small cell lung carcinoma: Next, we examined whether we could increase the sensitivity of NSCLC cells to TRAIL-induced anti-tumor activity by testing a combination of rhTRAIL (20 ng/mL) and RO3280 (50 nM) in all five NSCLC cell lines.